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Abstract
Objective To report a kindred with an association between hereditary primary lateral sclerosis (PLS) and progressive non-
fluent aphasia.
Patients and methods Six members from a kindred with 15 affected individuals spanning three generations, suffered from 
spasticity without muscle atrophy or fasciculation, starting in the lower limbs and spreading to the upper limbs and bulbar 
musculature, followed by effortful speech, nonfluent language and dementia, in 5 deceased members. Disease onset was 
during the sixth decade of life, or later. Cerebellar ataxia was the inaugural manifestation in two patients, and parkinsonism, 
in another.
Results Neuropathological examination in two patients demonstrated degeneration of lateral corticospinal tracts in the spinal 
cord, without loss of spinal, brainstem, or cerebral motor neurons. Greater loss of corticospinal fibers at sacral and lumbar, 
rather than at cervical or medullary levels was demonstrated, supporting a central axonal dying-back pathogenic mechanism. 
Marked reduction of myelin and nerve fibers in the frontal lobes was also present. Argyrophilic grain disease and primary 
age-related tauopathy were found in one case each, and considered incidental findings. Genetic testing, including exome 
sequencing aimed at PLS, ataxia, hereditary spastic paraplegia, and frontotemporal lobe dementia, triplet-repeated primed 
polymerase chain reaction aimed at dominant spinocerebellar ataxias, and massive sequencing of the human genome, yielded 
negative results.
Conclusion A central distal axonopathy affecting the corticospinal tract, exerted a pathogenic role in the dominantly inher-
ited PLS-progressive nonfluent aphasia association, described herein. Further molecular studies are needed to identify the 
causative mutation in this disease.
Keywords Primary lateral sclerosis · Motor neuron disease · Progressive nonfluent aphasia · Cerebellar ataxia · 
Parkinsonism · Dominant inheritance · Argyrophylic grain disease · Primary age-related tauopathy · Central distal 
axonopathy
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Introduction
Primary lateral sclerosis (PLS) is a rare spastic spinobulbar 
neurodegenerative disease, differentiated from amyotrophic 
lateral sclerosis (ALS) by preservation of lower motor neu-
rons. Primary progressive aphasia (PPA) is a variant of fron-
totemporal dementia (FTLD); to our knowledge, the asso-
ciation between hereditary PLS and progressive nonfluent 
aphasia, a subtype of PPA, has been rarely reported in the 
medical literature. Here, we describe a kindred with such an 
association, which spanned three generations.
Patients and methods
The pedigree of the family under study appears in Fig. 1, 
comprising 15 affected individuals over three generations. 
There was no familial consanguinity. Six affected individu-
als were examined by clinical neurologists, three of them 
(cases III-7, III-12, and III-21) by one of us (JG). We, there-
fore, describe in detail the clinical data of these patients, 
making a tabular summary of the remaining three patients.
Informed consents from surviving patient III-21 and 
relatives of deceased patients were obtained for all tests 
performed, and for publication. The study was in accord-
ance with the Declaration of Helsinki and the local ethics 
committee.
Clinical studies
Case III-21 [proband] A 65-year-old woman experienced 
progressively unsteady gait as of age 56, accompanied by 
dysarthria and episodes of choking; socially inappropriate 
remarks, emotional lability and irritability were noted later 
by family members.
On examination, she was alert and oriented. Spontane-
ous language consisted of short sentences with syntactic 
errors. Confrontation naming revealed phonemic parapha-
sia, single-word comprehension and sentence repetition 
being preserved. Speech was explosive, slow and effortful, 
with disrupted prosody. Spasticity was found in the hips and 
knees, Ashworth scale grade 2 [50], together with hyperac-
tive limb and jaw muscle stretch reflexes, and ankle clonus; 
plantar responses were indifferent. Limb muscle and tongue 
bulk and strength were normal, without fasciculation. Stance 
was wide-based, Romberg test was negative, gait was ataxo-
spastic requiring occasional support, and tandem gait was 
impossible. There was final tremor and slight dysmetria in 
the finger-to-nose and heel-to-shin manoeuvres (see vide-
otapes). Sensation was intact to pinprick, joint position and 
vibration. Eye movements were full, with no nystagmus, and 
ocular pursuit was smooth.
Neuropsychological testing performed 7 and 9 years 
after disease onset, using the Wisconsin Card Sorting Test, 
Boston Naming Test, Trail Making Tests A and B, Tower 
of London Test, Semantic Fluency Test (animals), Phone-
mic Verbal Fluency test, and the Barcelona Test, revealed 
a progressive decrease of speed in information processing, 
phonemic verbal fluency, and executive function, with perse-
veration and rigidity. Phonemic paraphasia was increasingly 
detected. A slight impairment in episodic memory did not 
worsen between tests, while attention, orientation to time 
and place, calculation, insight, and bidimensional construc-
tive praxis were preserved. Globally, these results outlined 
a frontosubcortical deterioration profile.
Case III-7 A previously healthy woman developed 
wide-based gait at the age of 70 years, accompanied by 
hand dysmetria. Muscle stiffness appeared in the legs and 
Fig. 1  Pedigree of the family. Horizontal bars under numbers indicate examined subjects; arrow indicates proband; slash lines indicate deceased 
individual. Squares are male and circles are female. Filled symbols indicate affected subjects, and empty symbols, unaffected subjects
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later in the arms, together with extremely painful spasms 
in the limbs and trunk, which abated spontaneously after 
5 years. Joint contractures developed, and she became bed-
ridden. Pseudobulbar affect, dysarthria, dysphagia, urinary 
and fecal incontinence subsequently ensued.
Twelve years after disease onset, progressively hesitant, 
halting, and scarce spontaneous language appeared, fol-
lowed by apathy, diminished social interest and memory 
impairment. The patient died aged 85.
On examination 5 months before death, spontaneous 
language was limited to very short sentences with syntac-
tic errors; she repeated single words and followed two-step 
commands. There was a spastic quadriparesis with flexion 
contractures at the elbows, wrists, hips, and knees; gait 
and limb coordination could not be tested. Tongue and 
limb muscle volume was normal, without fasciculation. 
Limb and jaw tendon reflexes were hyperactive, with ankle 
clonus, and plantar responses were extensor. Pain and 
vibration sense was preserved. Eye movements were full 
on vertical and lateral gaze, no nystagmus was observed, 
and ocular pursuit was saccadic. Speech was effortful and 
hypophonic, and snout and grasp reflexes were present.
Case III-12 A 62-year-old man developed hypomimia, 
bradikynesia and slow gait. On examination, left-sided 
cogwheel rigidity, slow left hand and foot tapping, and 
decreased arm sway during gait were noted. Parkinson’s 
disease was diagnosed and treated with rotigotin and 
pramipexole, without improvement. Two years later, pro-
gressive stiffness in the legs appeared, which spread to 
the arms, causing frequent and extremely painful spasms 
in the limbs and trunk (Ashworth scale grade 4, Tardieu 
scale grade 4, Penn Spasm Frequency Scale grade 3) [25, 
52], temporarily relieved by intrathecal baclofen. Dysar-
thria, dysphagia, and sphincter incontinence ensued, and 
he became wheelchair-bound 9 years after disease onset. 
At age 66, a progressively scarce, stuttering, and effort-
ful speech started, followed by apathy, emotional lability, 
ideas of prejudice, bouts of verbal and physical aggres-
siveness, and memory loss. Generalized spasticity without 
muscle atrophy was found on examination at age 69, and 
muscle strength was grade 4/5 [44]. Mini-Mental State 
Examination [19] score was 26/30, which fell to 20/30 
over 1 year, and he was diagnosed with PLS and FTLD. 
Death came at age 72.
On neurological examination at age 70, he was bedridden, 
alert with no spontaneous language, verbal answers limited 
to short sentences. Extreme spasticity was present in upper 
and lower limbs. Limb muscle and tongue bulk were normal, 
without fasciculation. Tendon reflexes were brisk, spontane-
ous ankle clonus was present, and plantar responses were 
extensor. Muscle strength was grade 4/5 [44].Stance and 
gait were impossible. Pain sensation was preserved. Facial 
hypomimia and fixed stare were observed. Extraocular 
movements were full and ocular pursuit was saccadic, with-
out nystagmus. Speech was effortful and hypophonic.
Tabular summary of clinical studies
Clinical data of all 6 examined individuals are summarized 
in Table 1. Age of onset varied from 52 to 70 years (median 
60). There were 5 deceased patients at ages ranging between 
70 and 85 years (median 75); median disease duration was 
15 years (range 10–25). Pyramidal semeiology initiated 
with spastic gait was the inaugural manifestation, which 
extended to the upper limbs and lower cranial nerve muscu-
lature, gradually causing quadriparesis with painful muscle 
spasms and pseudobulbar palsy. In no case was fasciculation 
or muscle atrophy observed. In addition, cases III-7 and III-
21 showed clear static and kinetic cerebellar ataxia, and case 
III-21 exhibited parkinsonism.
In a variable period of the clinical course, all six patients 
developed an alteration of language, initially consisting of 
effortful, halting, and dysprosodic speech, with phonemic 
paraphasia and reduced verbal fluency appearing later. With 
disease progression, apathy, followed by memory and ori-
entation difficulties, mutism and dementia, appeared in five 
cases. Cognitive deterioration following a frontosubcortical 
pattern was detected in case III-21.
Electrophysiological studies
In case III-16, an electromyographic study performed 
7 years after disease onset, revealed normal motor unit 
action potentials and absence of spontaneous activity in the 
deltoid, triceps brachii, first dorsal interosseous, quadriceps, 
medial gastrocnemius, and tibialis anterior muscles.
In case III-21, nerve conduction and electromyographic 
studies performed 6 years after disease onset revealed nor-
mal findings; no spontaneous muscle activity was recorded. 
Sensory evoked potentials were normal.
Imaging studies
MRI findings in case III-12 showed thinning of the trunk of 
the corpus callosum, dilation of supratentorial ventricles, 
and widening of central and frontoparietal sulci. Subcortical 
hyperintensities were detected in both central regions. Tem-
poral and occipital lobes were normal in appearance (Fig. 2).
In case III-21, MRIs performed 6 and 7 years after dis-
ease onset revealed thinning of the corpus callosum, ventric-
ular dilation and progressive dilation of frontoparietal and 
central sulci; the remaining intracranial structures displayed 
a normal appearance.
An amyloid positron emission tomography-computerized 
tomography (PET-CT) with florbetapir did not show abnor-
mal tracer binding.
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Neuropathological studies
Autopsy studies were performed on cases III.7 and III.12.
Case III.7 Macroscopically, the brain showed marked 
atrophy of the frontal lobes due to severely reduced white 
matter, with atrophy of the corpus callosum and ventricular 
dilation; the temporal lobes were normal (Fig. 3a).
Microscopic examination revealed marked reduction 
of myelin and nerve fibers, as revealed by myelin, myelin 
basic protein and neurofilament antibody stains. The primary 
motor cortex showed preservation of Betz neurons and mild 
astrogliosis (Fig. 3b).
A marked reduction of myelin and nerve fibers was 
found in the pyramidal tracts of the lumbar spinal cord, 
Table 1  Clinical manifestations of the kindred under study
F female, M male
Case II-6 Case III-7 Case III-9 Case III-12 Case III-16 Case III-21
Age at onset (years) 52 70 55 62 58 56
Age at death (years) 77 85 75 72 70 −
Disease duration (years) 25 15 20 10 12 9
Sex F F M M M F
Spasticity + + + + + +
Brisk tendon reflexes + + + + + +
Ankle clonus Not mentioned + + + + +
Plantar responses Extensor bilateral Extensor bilateral Extensor bilateral Extensor bilateral Extensor bilateral Indifferent
Muscle atrophy − − − − − −
Fasciculation − − − − − −
Ataxia Not mentioned + − − − +
Parkinsonism Not mentioned − − + − −
Dysarthria/dysphagia + + + + + +
Urinary incontinence + + + + + −
Nonfluent speech + + + + + Impaired pho-
nemic verbal 
fluency
Apathy + + + + + −
Other behavioural symp-
toms






Dementia + + + + + −
Fig. 2  MRI study in case III-12. a Cranial MRI axial T2-weighted 
image showing frontoparietal atrophy and sulcal enlargement, espe-
cially of the central sulci (SC). b Coronal T2-FLAIR image shows 
subtle subcortical hyperintensity underlying the dilated intrapari-
etal sulci (IS), and atrophy of the gyrus parietalis superior (GPS). c 
Midsagittal T2-weighted image showing atrophy of the trunk of the 
corpus callosum (CC), and enlargement of the marginal branch of the 
cingulated (MBCS) and precentral sulci (PS)
Journal of Neurology 
1 3
the only level available for study (Fig. 3c). Spinal motor 
neurons were preserved, with a few axonal balloonings in 
the anterior horn. In addition, abundant 4Rtau pre-tangles 
and grains, and a few tangles were observed in the hip-
pocampus and entorhinal cortex, accompanied by thorn-
shaped astrocytes and abundant oligodendrocytes with 
tau deposits conforming coiled bodies, in the temporal 
white matter (Fig. 3d). Abnormal TDP-43, α-synuclein or 
β-amyloid deposits were not detected.
Case III.12 The primary motor cortex displayed normal 
neuronal populations (Fig. 4a–c), and so did other regions 
of the frontal and parietal cortices.
Degeneration of the lateral and, to a lesser extent, ante-
rior corticospinal fascicles with axon and myelin loss, 
moderate astrogliosis, and absence of microglial response, 
macrophages or inflammatory cells, was the main altera-
tion in the spinal cord. Degeneration was much more 
marked at sacral and lumbar, than at cervical spinal cord 
and medullary levels (Fig. 5a–d). No neuronal loss or cell 
body alteration was noted in the anterior horns of the spi-
nal cord, except for a few ballooned axons in the ante-
rior horn in the distal spinal cord and in Clarke’s column 
(a normal finding with aging in this region, Fig. 5g, h)). 
Other spinal cord fascicles were not affected; myelin and 
nerve fibers were preserved in the spinal roots and dorsal 
tracts (Figs. 4d–g, 5e, f).
The cerebellum showed moderate loss of Purkinje cells 
with occasional torpedoes and empty baskets (Fig. 4j). Mod-
erate neuronal loss was observed in the bulbar olive (greater 
than corresponding to age), accompanied by moderate astro-
cytosis but no reactive microglia. No alteration was found 
in the nucleus of the hypoglossal nerve, motor nucleus of 
the vagus nerve, oculomotor and pontine nuclei, red nuclei, 
colliculi or substantia nigra.
Only one section each of the anterior caudate, putamen, 
and pulvinar nucleus was available for study; no neuronal 
alterations were seen.
Neurofibrillary tangles (NFT) composed of 4Rtau and 
3Rtau were observed in the hippocampus and entorhinal cor-
tex (Fig. 4h, i). Abnormal TDP-43, α-synuclein or β-amyloid 
deposits were not observed in any region.
To summarize, the neuropathological studies showed: 
(1) degeneration of the lateral corticospinal tracts, with an 
axonal dying-back pattern in case III.12; (2) preservation of 
spinal, brainstem and cortical motor neurons; (3) severe atro-
phy of the frontal white matter and corpus callosum in case 
III-7; (4) cerebello-olivary degeneration, mainly affecting 
Purkinje cells in case III.12; (5) argyrophilic grain disease 
Fig. 3  Autopsy features in Case III-7. a Macroscopic coronal section 
showing atrophy of the frontal lobes, reduction in the white matter 
of the centrum semiovale and corpus callosum, enlargement of lateral 
ventricles and normal temporal lobes. b Microscopic section of the 
motor cortex (MC) showing preservation of Betz neurons (Klüver-
Barrera; bar = 45  µm). c In this transverse section of the lateral 
pyramidal tract, note marked reduction of axons in the lateral pyrami-
dal tract (anti-neurofilament 200  kDa antibody, clone RT97; bar 
= 25 µm). d Section of the hippocampus (CA1 region) showing neu-
rons with deposits of hyperphosphorylated tau and grains (Phospho-
Tau [Ser202, Thr205] Monoclonal Antibody AT8; bar = 225  µm). 
Sections processed for immunohistochemistry are slightly counter-
stained with hematoxylin
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(AGD) stage III in case III-7; and (6) primary age-related 
tauopathy (PART) in case III-12.
Genetic testing
In case III-7, an exome panel aimed at PLS (24 genes) did 
not detect pathogenic variants, or variants of unknown sig-
nificance (VUS). In addition, microarray-based Compara-
tive Genomic Hybridization (aCGH) 400K was performed to 
detect deletions in genes involved in PLS, especially TBK1, 
with negative results.
Finally, massive sequencing of the human genome was 
carried out to identify genomic variants: (1) single nucle-
otide (SNV) and insertion–deletion (INDEL) variants 
included in exonic regions, 3´UTR and 5′UTR regions, and 
all intron variants described as probably pathogenic or path-
ogenic in the ClinVar database (v20150330); and (2) copy 
number variations in exonic, intronic or intergenic regions. 
No pathogenic variants associated with the object of consul-
tation were identified. However, a low-frequency population 
VUS was identified in a gene that has compatible signs with 
the phenotype under study, with which it was not possible 
to establish an association: p.(Pro656Thr), exon 17, MED25 
[NM_030973.3:c.1966C > A], missense variant, carrier in 
heterozygosis.
In case III-12, MLPA (Multiplex Ligation-dependent 
Probe Amplification) aimed at the hereditary spastic 
paraparesis (HSP) genes SPAST, NIPA1 (SPG6), SPG7, 
REEP1 (SPG31), and ALT1 (SPG3A) was negative. A 
Fig. 4  Histological features in Case III-12. a–c Sections of primary 
motor cortex (MC) stained with hematoxylin and eosin (HE), mye-
lin basic protein (MBP), and glial fibrillary acidic protein (GFAP), 
showing neuronal preservation and absence of reactive astrocytosis 
(bar = 45  µm). Transverse sections of the spinal cord at the cervi-
cal level showing preservation of the dorsal columns (d) and loss of 
myelinated fibers in the lateral pyramidal tract (e) (Klüver-Barrera; 
bar = 45  µm). f, g Note absence of alterations in anterior (ant root) 
or dorsal roots of the spinal cord (Klüver-Barrera; bar = 100  µm). 
h–j Neurofibrillary degeneration visualized with AT8 antibody in the 
entorhinal cortex (EC) and CA1 region of the hippocampus (CA1, bar 
= 100  µm); section of the cerebellar cortex (bar = 25  µm) showing 
axonal ballooning, as revealed with anti-phosphorylated neurofila-
ment antibodies (RT97). Sections processed for immunohistochemis-
try are slightly counterstained with hematoxylin
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Next Generation Sequencing (NGS) panel study of 27 
genes associated with HSP was also negative.
In Case III-16, MLPA of SPAST, NIPA, SPG7, REEP, and 
ALT genes was negative.
In Case III-21, an initial molecular study performed with 
Triplet-repeated Primed Polymerase Chain Reaction (TP-
PCR) of autosomal dominant spinocerebellar ataxias (SCA) 
1, 2, 3, 6, 7, 8, 10, 12, and 17 and dentatorubral–pallidoluy-
sian atrophy, yielded negative results. Dynamic expansions 
of the GGG GCC hexamer in intron 1 of C9orf72 were ruled 
out, as was the presence of large deletions/duplications 
(MLPA) in the analyzed regions of MAPT and GRN.
An NGS study of the human exome was performed to 
identify genomic variants in 145 genes associated with ataxia, 
HSP, and FTLD/exome directed, without finding pathogenic 
variants or VUS. An extension was made to the clinical exome 
study by NGS (5713 genes), and the following low-frequency 
allelic variants (< 1%) and VUS were detected in heterozygo-
sis: (1) c.134C > A (p.Pro45Gln), missense, SPAST (in silico 
pred 3/8); (2) c.666C > A (p.Tyr222*), nonsense, MMACHC; 
(3) c.5118C > A (p.Asn1706Lys) exon 40, missense, (4) ITPR1 
(in silico pred 2/8); and (5) c.1486C > T (p.Pro496Ser) exon 
13, missense, TTBK2 (in silico pred 1/8). Sanger sequencing 
of these variants was negative in case III-16, variant number 4 
being positive only in case III-12.
Discussion
The core clinical features of the kindred under study were 
spastic spinobulbar paresis without muscle atrophy, and 
dementia characterized by inaugural speech disturbance. 
Fig. 5  Case III-12. Sections of medulla oblongata (a) and spinal cord 
(b cervical; c lumbar; d sacral) processed for immunohistochemistry 
with anti-phosphorylated neurofilament antibodies (RT97), showing 
axonal loss in the crossed pyramidal tract, more intense at sacral than 
at lumbar, cervical and medullary levels, and very discrete axonal 
loss in the anterior pyramidal tract (e); conversely, axons in the dor-
sal column (f) are preserved (bar = 25 µm). g, h Axonal ballooning is 
seen in the lumbar and sacral anterior horn of the spinal cord and in 
Clarke’s column (i) (RT97, bar = 45 µm). Sections slightly counter-
stained with hematoxylin
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Disease onset was in the sixth decade of life or later, 
and inheritance was autosomal dominant with complete 
penetrance.
The motor manifestations exhibited by this family 
fulfilled the clinical diagnostic criteria of PLS [56]: (1) 
insidious onset of spastic paresis, beginning in the lower 
extremities; (2) onset in the fifth decade or later; (3) grad-
ually progressive course (duration ≥ 3 years; (4) clinical 
findings limited to corticospinal dysfunction; and (5) sym-
metrical distribution, ultimately developing spastic spin-
obulbar paresis. Criterion number 3 (absence of family 
history) was not met.
Juvenile PLS may be sporadic but also inherited in a 
recessive mode, the causative mutant gene being ALS2 on 
chromosome 2q33.1, which is also responsible for infan-
tile-onset ascending spastic paralysis and a juvenile form 
of ALS [25, 46, 51]. Erb claimed that PLS could be heredi-
tary [18], albeit recent examples of adult onset autosomal 
dominant PLS are limited to a kinship with compound 
heterozygote mutations in SPG7, and a French–Canadian 
family, in which a locus was identified on chromosome 
4 [15, 69, 73]. Adult onset PLS is not caused by muta-
tions in ALS2 [5], but apparently sporadic cases have been 
related to mutations in SPG7, SPG11, DCTN1, PARK2, 
and expansions in C9orf72 [47, 72]. Isolated instances of 
PLS may occur within FTLD [21] and ALS pedigrees [4, 
55, 58], such as those associated with mutations in TBK1 
and UBQLN2, respectively [72]. None of the mentioned 
variants was found in this study.
PLS is rare, comprising about 5% of motor neuron dis-
ease [MND] patients presenting at specialized neuromus-
cular clinics [49]. The controversy about whether PLS is a 
subtype of ALS or a discrete entity continues to this day [22, 
26]: revised El Escorial criteria consider PLS a restricted 
ALS phenotype [40], while other authors maintain PLS is a 
distinct syndrome [13].
Our patients had no lower motor neuron signs; in conse-
quence, electrophysiological testing was performed only in 
cases III-16 and III-21, in which electromyographic studies 
were, respectively, normal, 7 and 6 years after disease onset.
The manifestations displayed by this kindred fell into 
the category of PLS-plus (complicated PLS): “predomi-
nant upper motor neuron signs plus clinical, laboratory, or 
pathological evidence of dementia, parkinsonism, or sen-
sory abnormalities”, because “spastic spinobulbar paralysis 
without muscle atrophy, visible fasciculations or evidence 
of denervation on electromyography at ≥ 4 years from dis-
ease onset” [22, 39, 62], together with dementia or cognitive 
decline, was present in every case.
Case III-12 associated dopamine agonist therapy-resist-
ant parkinsonism with PLS, as reported in PLS-plus [20, 
22, 41, 62]. Although the substantia nigra was normal on 
pathological examination, assessment of the basal ganglia 
could not be performed in depth, precluding any potential 
clinicopathological correlation.
Cerebellar ataxia has not been considered a component of 
PLS-plus, its presence making it necessary to differentiate 
PLS-plus from multiple system atrophy [20, 40]. However, 
cerebellar intention tremor and unsteady gait were reported 
in a family with MND and dementia [two members express-
ing PLS], in correlation with loss of Purkinje cells [54]. 
Patients III-7 and III-21 exhibited inaugural unsteady gait 
and dysmetria, although no histological abnormalities were 
present in the cerebellum in the first case. Contrariwise, cer-
ebello-olivary degeneration was found in case III-12, in spite 
of an absence of ataxic signs. The presence of cerebellar 
ataxia in this context could be related to factors that modify 
the expression of the causative gene and induce differing 
clinical and pathological manifestations, as demonstrated 
in hereditary ataxia [61].
In spite of preserved bladder function being considered 
part of PLS [56], urinary incontinence was present in five 
of our cases and urinary urgency in the other, as reported in 
PLS [39, 47], the cause being detrusor hyperreflexia and a 
spastic internal vesical sphincter [59].
PLS is considered to spare intellect, although impairment 
in executive function, verbal memory, psychomotor speed 
and verbal fluency (similar to ALS and progressive mus-
cular atrophy) has been identified in up to 49% of patients 
[8, 12, 53]. In one study, total score on the Addenbrooke’s 
Cognitive Examination was abnormal in 21 patients with 
PLS (mean 82.5/100, cutoff value 88), the most prominent 
deficits being reduced verbal fluency, and deficiencies in 
memory, language and visuospatial function [1].
PLS is not believed to form part of the FTLD–MND com-
plex; however, this association has been reported before [14, 
29]. In one series, 3.3% of PLS cases developed FTLD of the 
behavioural or semantic variants [12]. Rapid and severe cog-
nitive decline appeared years after progressive UMN signs, 
with memory impairment never being an early symptom, 
as observed in this kindred, in which similar time courses 
of evolution and progression of symptoms, suggest a com-
mon pathogenic origin for motor and cognitive symptoms. 
Amyloid was absent in pathological material [1], as in our 
neuropathological and florbetapir PET-CT studies, ruling 
out Alzheimer’s disease as the present illness’ cause.
Every investigated member in this kin suffered from 
dementia starting up to 12 years after motor symptom onset, 
except for patient III-21 (who only exhibited frontosubcor-
tical deterioration after 8 years of disease). Early speech 
(halting, stuttering and effortful speech) and language dis-
turbances (agrammatism, decreased verbal fluency and pho-
nemic paraphasia) preceded apathy, emotional lability, and 
memory impairment. These manifestations were evaluated 
against clinical criteria for PPA, and a nonfluent/agrammatic 
variant was diagnosed [23]. Aggressiveness and delusional 
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ideas occurred in case III-12, and social disinhibition and 
emotional lability in case III-21; however, clinical diagnostic 
criteria for behavioural variant FTLD were not met [9, 23].
Nonfluent PPA has been related to potential development 
of ALS and other motor syndromes [16, 30, 64], as found 
in this family. It was mentioned in association with PLS 
in one case, but no clinical description was provided [34]. 
Deposition of tau protein predominating in the left posterior 
frontoinsular cortex is the most likely pathological basis [30, 
33], although in this study, tau deposition was found in the 
form of AGD in case III-7, and of PART in case III-12.
AGD is an age-related 4R tauopathy. It may overlap with 
other neurodegenerative disorders and is second only to Alz-
heimer’s disease in frequency, although no association with 
the APOE ε4 genotype has been reported. It is character-
ized by three main pathological features: argyrophilic grains, 
oligodendrocytic coiled bodies, and neuronal cytoplasmatic 
pre-tangles in the medial temporal lobes, as found in case 
III-7. AGD lacks distinctive clinical features and may mani-
fest as a slowly progressive amnestic syndrome; however, up 
to 59% of cases with pathologically demonstrated AGD were 
cognitively normal [31, 57].
PART refers to the presence of age-related 3R and 4R 
tau-positive NFT in neurons, without extension beyond the 
temporal neocortex. Whether PART represents early Alz-
heimer’s disease remains controversial, as the frequency 
of association with APOE ε4 is low [33, 57]. A diagnosis 
of PART requires a Braak NFT stage ≤ IV (usually III or 
lower), and a Thal beta-amyloid phase ≤ 2. PART is clas-
sified pathologically as definite or possible, depending on 
whether beta-amyloid is absent or present, respectively [10, 
32]. Clinically, it may be divided into asymptomatic (no 
cognitive decline or dementia), or symptomatic (cognitive 
decline or dementia present); [10]; case III-12 can be clas-
sified as definite, symptomatic PART.
Definite PART may go either with normal intellect, mild 
cognitive impairment or dementia, as no precise clinical 
features have been outlined for it. Depression, increasing 
Braak stage, and presence of other tau pathologies or neu-
rodegenerative diseases have been associated with definite, 
symptomatic PART [3].
AGD and PART do not affect the left frontoinsular cortex 
involved in nonfluent PPA, and have not been previously 
associated with PLS in the medical literature; therefore, 
they must be considered incidental findings in the present 
kindred.
Neuropathological examination of cases with PLS and 
dementia have revealed corticospinal tract degeneration, 
preservation of spinal motor neurons and loss of cerebral 
cortex neurons, which displayed either ubiquitin-positive 
tau [66], ubiquitin-positive [36, 48], TDP-43 [29, 34, 37], 
neurofilament-immunoreactive neuronal inclusions [42], 
dendritic ballooning [65], or diffuse beta-amyloid plaques 
[17]. Every one of these cases was sporadic, and the data 
provided were insufficient to define a dementing syndrome 
characteristic of PLS. None of the aforementioned cortical 
changes was found in our autopsied cases.
A diagnosis of autopsy-proven PLS in this study was 
corroborated by degeneration of corticospinal tracts in 
the spinal cord and bulbar pyramids without neuron loss, 
gliosis, Bunina bodies, ubiquitin or TDP-43 inclusions, in 
spinal motor neurons [22]. The more pronounced corti-
cospinal fiber loss at sacral and lumbar, rather than at cer-
vical and medullary levels found in case III-12, supports 
by pathological means a dying-back pathogenic mecha-
nism, in which central axons degenerate following a dis-
tal-to-proximal gradient, as previously proposed for PLS 
[11, 74]. Moreover, preservation of upper motor neuron 
cell bodies indicated that a cerebral cortical neuronopathy 
could not be claimed as causal in cases III-7 and III-12.
Marked loss of myelin and nerve fibers in the frontal 
and parietal lobes without deposition of abnormal mate-
rial, was found in case III-7. Taken together, these data 
suggest that white matter degeneration centered on axonal 
motor and language networks could be a primary patho-
logic alteration in this kindred [27, 34, 67].
Central distal axonopathies have been implied as causal 
mechanisms in HSP, lathyrism, Friedreich’s ataxia, ALS 
and clioquinol intoxication [38, 68, 74]. A primary cen-
tral axonopathy that affects language structures has been 
proposed for progressive nonfluent aphasia on the basis of 
white matter damage on MRI [60], as found in case III.12.
MRI demonstrated dilation of central sulci in this series 
[as reported in PLS], enlarged frontoparietal sulci and lat-
eral ventricles, bilateral white matter abnormalities in the 
corona radiata and atrophy of the corpus callosum; the 
last two have been associated with PLS and PPA [2, 35, 
56, 63]. In addition, impairment in memory, executive and 
language test scores in PLS, has been found to correlate 
with white matter tract damage on diffusion-tensor MRI 
[7, 45].
The main differential diagnosis in this kindred would be 
FTLD–MND, excluded by absence of lower motor neuron 
clinical, electromyographic and pathological signs, and a 
mean survival time of 196.8 months, approximately equiva-
lent to 217 ± 22.4 months in one series [53]. This is in con-
trast with FTLD–MND, whose mean duration was estimated 
as 2–3 years [29], and 38.5 ± 4.5 months [28]. SPG4, SPG7, 
and SPG11 were also considered in the differential diagnosis 
[6, 69, 71], as well as SCA1 and SCA17 in cases III-7 and 
III-21, because these exhibited cerebellar ataxia in addition 
to spasticity and cognitive decline [43, 70]. All these dis-
eases were ruled out by genetic analysis. Furthermore, no 
potentially pathogenic gene mutations were identified on 
NGS whole exome sequencing, covering 5.713 genes, and 
whole genome sequencing.
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In summary, a kindred with a hitherto undescribed, domi-
nantly inherited variant of PLS and progressive nonfluent 
aphasia, in which the corticospinal tracts were affected by 
a central distal axonopathy, and cortical motor neurons 
were preserved, is presented. Further molecular studies are 
needed to identify the causative mutation in this disease, to 
offer accurate genetic counseling to the family under study.
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